AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 29th, 2007 • Achillion Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”), effective as of the 10th day of September, 2003, is entered into by Achillion Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 300 George Street, New Haven, CT 06511-6624 (the “Company”), and Mary Kay Fenton, residing at 1381 Farmington Avenue, West Hartford, CT 06107 (the “Employee”). This Agreement amends and restates the Employment Agreement between the Company and the Employee dated October 5, 2000 (the “Original Agreement”).
AMENDMENT NO. 1 TO RESEARCH COLLABORATION AND LICENSE AGREEMENTResearch Collaboration and License Agreement • March 29th, 2007 • Achillion Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Amendment No. 1 to the Research Collaboration and License Agreement (the “Amendment”), effective as of March 26, 2007, modifies certain provisions of the Research Collaboration and License Agreement (the “Agreement”) entered into as of November 24, 2004, between Achillion Pharmaceuticals, Inc., 300 George Street, New Haven, Connecticut 06511 (“Achillion”), and Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404 (“Gilead”). Capitalized terms used and not otherwise defined herein shall have the meanings assigned to such terms in the Agreement.
